Charles Antoine Coupet

Title: Charles Antoine Coupet: Innovator in Mycobacterial Antigen Vaccines

Introduction

Charles Antoine Coupet is a notable inventor based in Lyons, France. He has made significant contributions to the field of immunology, particularly through his work on vaccines targeting mycobacterial infections. His innovative approach has the potential to enhance immune responses against various diseases.

Latest Patents

Charles Antoine Coupet holds a patent for a mycobacterial antigen vaccine. This invention relates to immunogenic combinations that comprise at least five antigens of a species, as well as their fusion and nucleic acid molecules encoding such combined antigens. The patent also covers vectors, host cells, and compositions that include these combinations of mycobacterial antigens and fusion polypeptides. Furthermore, it outlines methods for recombinantly producing these components and their applications in inducing immune responses against infections.

Career Highlights

Coupet is associated with Transgene S.A., a company that focuses on developing innovative immunotherapies. His work at Transgene has allowed him to contribute to advancements in vaccine technology and immunogenic research. His patent reflects his commitment to addressing public health challenges through scientific innovation.

Collaborations

Some of his notable coworkers include Emmanuel Tupin and Romain Micol. Their collaborative efforts in research and development have furthered the understanding and application of mycobacterial antigens in vaccine formulation.

Conclusion

Charles Antoine Coupet's contributions to the field of immunology, particularly through his patent on mycobacterial antigen vaccines, highlight his role as an innovator in the scientific community. His work continues to pave the way for advancements in vaccine technology and public health.